Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mylan NV (NASDAQ:MYL)

38.51
Delayed Data
As of Oct 20
 +0.22 / +0.57%
Today’s Change
29.39
Today|||52-Week Range
45.87
+0.94%
Year-to-Date
Diamond Hill's Top 3 New Investments for the 3rd Quarter
Oct 19 / GuruFocus News - Paid Partner Content
Mylan Gets Complete Response Letter For Biosimilar Neulasta
Oct 11 / Zacks.com - Paid Partner Content
Pricing Pressure, Competition Remain Headwinds for Pharma Stocks
Oct 18 / Zacks.com - Paid Partner Content
Forget Teva (TEVA), Buy These 5 Drug Stocks Instead
Oct 09 / Zacks.com - Paid Partner Content
Allergan (AGN) Loses Restasis Patent Lawsuit, Shares Fall
Oct 17 / Zacks.com - Paid Partner Content
US FDA approves generic competitor of Teva blockbuster drug
Oct 04 / FT.com - Paid Partner Content
Voyager Therapeutics (VYGR) Jumps: Stock Rises 7.8%
Oct 13 / Zacks.com - Paid Partner Content
Allergan deal with Mohawk tribe casts patent shadow
Sep 27 / FT.com - Paid Partner Content